KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Total Current Liabilities (2016 - 2025)

Historic Total Current Liabilities for Idexx Laboratories (IDXX) over the last 17 years, with Q3 2025 value amounting to $1.3 billion.

  • Idexx Laboratories' Total Current Liabilities rose 2403.7% to $1.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 billion, marking a year-over-year increase of 2403.7%. This contributed to the annual value of $1.1 billion for FY2024, which is 1222.95% up from last year.
  • According to the latest figures from Q3 2025, Idexx Laboratories' Total Current Liabilities is $1.3 billion, which was up 2403.7% from $1.2 billion recorded in Q2 2025.
  • Idexx Laboratories' 5-year Total Current Liabilities high stood at $1.3 billion for Q3 2025, and its period low was $620.7 million during Q1 2021.
  • Over the past 5 years, Idexx Laboratories' median Total Current Liabilities value was $1.0 billion (recorded in 2024), while the average stood at $993.0 million.
  • As far as peak fluctuations go, Idexx Laboratories' Total Current Liabilities crashed by 2665.66% in 2021, and later soared by 8773.32% in 2022.
  • Over the past 5 years, Idexx Laboratories' Total Current Liabilities (Quarter) stood at $763.6 million in 2021, then surged by 61.84% to $1.2 billion in 2022, then fell by 23.0% to $951.5 million in 2023, then increased by 12.23% to $1.1 billion in 2024, then increased by 17.22% to $1.3 billion in 2025.
  • Its last three reported values are $1.3 billion in Q3 2025, $1.2 billion for Q2 2025, and $1.1 billion during Q1 2025.